Cargando…

The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease

Neuropsychiatric symptoms (NPS) occur in nearly all patients with Alzheimer's Disease (AD). Most frequently they appear since the mild cognitive impairment (MCI) stage preceding clinical AD, and have a prognostic importance. Unfortunately, these symptoms also worsen the daily functioning of pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krashia, Paraskevi, Spoleti, Elena, D'Amelio, Marcello
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618946/ https://www.ncbi.nlm.nih.gov/pubmed/36325523 http://dx.doi.org/10.3389/fpsyt.2022.1039725

Ejemplares similares

Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease
por: Krashia, Paraskevi, et al.
Publicado: (2019)

Calcium handling: a strategy to fight neurodegeneration in Alzheimer’s disease
por: La Barbera, Livia, et al.
Publicado: (2023)

Upregulation of Ca(2+)-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer’s disease in Tg2576 mice
por: La Barbera, Livia, et al.
Publicado: (2022)

Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer's disease?
por: D’Amelio, Marcello, et al.
Publicado: (2023)

The Role of Dopaminergic VTA Neurons in General Anesthesia
por: Zhou, Xuelong, et al.
Publicado: (2015)

Ventral tegmental area disruption in Alzheimer’s disease
por: Bozzali, Marco, et al.
Publicado: (2019)

In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases
por: Sala, Arianna, et al.
Publicado: (2021)

Resilience to anhedonia-passive coping induced by early life experience is linked to a long-lasting reduction of I(h) current in VTA dopaminergic neurons
por: D'Addario, Sebastian Luca, et al.
Publicado: (2021)

NMDA Receptors on Non-Dopaminergic Neurons in the VTA Support Cocaine Sensitization
por: Luo, Yu, et al.
Publicado: (2010)

Circadian regulation of hedonic appetite in mice by clocks in dopaminergic neurons of the VTA
por: Koch, C. E., et al.
Publicado: (2020)

Comparison between dopaminergic and non-dopaminergic neurons in the VTA following chronic nicotine exposure during pregnancy
por: Keller, Renee F., et al.
Publicado: (2019)

Nilotinib: from animal-based studies to clinical investigation in Alzheimer’s disease patients
por: Nobili, Annalisa, et al.
Publicado: (2022)

Investigating the effects of chronic perinatal alcohol and combined nicotine and alcohol exposure on dopaminergic and non-dopaminergic neurons in the VTA
por: Kazemi, Tina, et al.
Publicado: (2021)

Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer’s disease models
por: Corsetti, Veronica, et al.
Publicado: (2020)

Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives
por: La Barbera, Livia, et al.
Publicado: (2022)

Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage
por: Caligiore, Daniele, et al.
Publicado: (2020)

Reducing Addiction in Bipolar Disorder via Hacking the Dopaminergic System
por: Grunze, Heinz, et al.
Publicado: (2021)

Investigating the influence of PFC transection and nicotine on dynamics of AMPA and NMDA receptors of VTA dopaminergic neurons
por: Chen, Ting, et al.
Publicado: (2011)

TLR4 signaling in VTA dopaminergic neurons regulates impulsivity through tyrosine hydroxylase modulation
por: Aurelian, L, et al.
Publicado: (2016)

Activation of the dopaminergic pathway from VTA to the medial olfactory tubercle generates odor-preference and reward
por: Zhang, Zhijian, et al.
Publicado: (2017)

Inflammation in VTA Caused by HFD Induces Activation of Dopaminergic Neurons Accompanied by Binge-like Eating
por: Sun, Runan, et al.
Publicado: (2022)

Reduction in the activity of VTA/SNc dopaminergic neurons underlies aging-related decline in novelty seeking
por: Shan, Qiang, et al.
Publicado: (2023)

Reward enhances resilience to chronic social defeat stress in mice: Neural ECs and mGluR5 mechanism via neuroprotection in VTA and DRN
por: Shi, Peixia, et al.
Publicado: (2023)

The Apoptosome: Emerging Insights and New Potential Targets for Drug Design
por: D’Amelio, Marcello, et al.
Publicado: (2007)

Activation of dopaminergic VTA inputs to the mPFC ameliorates chronic stress‐induced breast tumor progression
por: Xu, Xi‐Rong, et al.
Publicado: (2020)

Chemogenetic rectification of the inhibitory tone onto hippocampal neurons reverts autistic-like traits and normalizes local expression of estrogen receptors in the Ambra1+/- mouse model of female autism
por: Pignataro, Annabella, et al.
Publicado: (2023)

Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease
por: Nobili, Annalisa, et al.
Publicado: (2017)

Anti-microRNAs as Novel Therapeutic Agents in the Clinical Management of Alzheimer's Disease
por: Zhao, Yuhai, et al.
Publicado: (2016)

Validity of the QUADAS-2 in Assessing Risk of Bias in Alzheimer's Disease Diagnostic Accuracy Studies
por: Venazzi, Alisson, et al.
Publicado: (2018)

Editorial: Alzheimer's Disease From a Psychiatric Perspective: Towards New Therapeutic Guidelines?
por: Fakhoury, Marc, et al.
Publicado: (2021)

Dopaminergic, Noradrenergic, Adrenal, and Thyroid Abnormalities in Psychotic and Affective Disorders
por: Duval, Fabrice, et al.
Publicado: (2020)

CB(2) Cannabinoid Receptor As Potential Target against Alzheimer's Disease
por: Aso, Ester, et al.
Publicado: (2016)

Inhibition of SK Channels in VTA Affects Dopaminergic Neurons to Improve the Depression-Like Behaviors of Post-Stroke Depression Rats
por: Wang, Anqi, et al.
Publicado: (2023)

α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin
por: Lieberman, Ori J., et al.
Publicado: (2017)

Meditation as a Therapeutic Intervention for Adults at Risk for Alzheimer’s Disease – Potential Benefits and Underlying Mechanisms
por: Innes, Kim E., et al.
Publicado: (2014)

Noradrenergic dysfunction in Alzheimer's disease
por: Gannon, Mary, et al.
Publicado: (2015)

Editorial for Special Issue: Microbial and Autoimmune Disease
por: D’Amelio, Raffaele
Publicado: (2021)

Investigating the genetic profile of dopaminergic neurons in the VTA in response to perinatal nicotine exposure using mRNA-miRNA analyses
por: Keller, Renee F., et al.
Publicado: (2018)

Whole-brain opto-fMRI map of mouse VTA dopaminergic activation reflects structural projections with small but significant deviations
por: Ioanas, Horea-Ioan, et al.
Publicado: (2022)

Dopaminergic Dysregulation in Prefrontal Cortex of Rhesus Monkeys Following Cocaine Self-Administration
por: McIntosh, Scot, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vkjkams7uqrnbl8475g8q5c1ph